164 related articles for article (PubMed ID: 4120196)
1. Some recent studies on cellular immunity to human melanomas.
Hellström I; Hellström KE
Fed Proc; 1973 Feb; 32(2):156-9. PubMed ID: 4120196
[No Abstract] [Full Text] [Related]
2. Studies of humoral and cell-mediated immunity in human melanoma.
Mukherji B; Nathanson L; Clark DA
Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
[No Abstract] [Full Text] [Related]
3. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
Hellström I; Hellström KE
Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
[No Abstract] [Full Text] [Related]
4. Immunological studies on malignant melanomas of man.
Romsdahl MM; Cox IS
Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
[No Abstract] [Full Text] [Related]
5. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
Hellström I; Warner GA; Hellström KE; Sjögren HO
Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
[No Abstract] [Full Text] [Related]
6. Immune responses induced by human malignant melanoma in the rabbit.
Goodwin DP; Hornung MO; Leong SP; Krementz ET
Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
[No Abstract] [Full Text] [Related]
7. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
[No Abstract] [Full Text] [Related]
8. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells.
Saal JG; Rieber EP; Hadam M; Riethmuller G
Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919
[No Abstract] [Full Text] [Related]
9. Abrogation of cell-mediated immunity by hyperimmune alloantiserum: mechanisms and correlation with allograft enhancement.
Cohen JM; Yang SS; Law LW
Int J Cancer; 1974 Apr; 13(4):463-77. PubMed ID: 4135340
[No Abstract] [Full Text] [Related]
10. Blocking of syngeneic effector T cells by soluble tumour antigens.
Plata F; Levy JP
Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
[No Abstract] [Full Text] [Related]
11. Destruction of cultivated melanoma cells by lymphocytes from healthy Black (North American Negro) donors.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1973 Jan; 11(1):116-22. PubMed ID: 4790830
[No Abstract] [Full Text] [Related]
12. Immunology and the melanomas.
Lewis MG
Curr Top Microbiol Immunol; 1974; 63():49-84. PubMed ID: 4597749
[No Abstract] [Full Text] [Related]
13. Immunity to neuroblastomas and melanomas.
Hellström KE; Hellström I
Annu Rev Med; 1972; 23():19-38. PubMed ID: 4566479
[No Abstract] [Full Text] [Related]
14. Immunological aspects of the etiology of human leukemia.
Penny R
Ser Haematol; 1974; 7(2):274-99. PubMed ID: 4139757
[No Abstract] [Full Text] [Related]
15. Some aspects of the immune defense against cancer. II. In vitro studies on human tumors.
Hellström I; Hellström KE
Cancer; 1971 Nov; 28(5):1269-71. PubMed ID: 5125674
[No Abstract] [Full Text] [Related]
16. Tumor-associated membrane antigens and the antitumor immune reactions.
Levy JP; Kourilsky FM
Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
[No Abstract] [Full Text] [Related]
17. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.
Wybran J; Hellström I; Hellström KE; Fudenberg HH
Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321
[No Abstract] [Full Text] [Related]
18. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
Ferrone S; Pellegrino MA
J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
[TBL] [Abstract][Full Text] [Related]
19. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.
Wagner H; Röllinghoff M; Nossal GJ
Transplant Rev; 1973; 17(0):3-36. PubMed ID: 4151904
[No Abstract] [Full Text] [Related]
20. Cellular and humoral immunity against human malignant melanoma.
Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
